mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile

The aim of this study was to determine the serum profiles of miRNAs in patients with tuberous sclerosis (TSC) upon sirolimus treatment and compare them with those previously treated with everolimus in a similarly designed experiment. Serum microRNA profiling was performed in ten TSC patients before...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlik, Bartłomiej, Smyczyńska, Urszula, Grabia, Szymon, Fendler, Wojciech, Dróżdż, Izabela, Bąbol-Pokora, Katarzyna, Kotulska, Katarzyna, Jóźwiak, Sergiusz, Borkowska, Julita, Młynarski, Wojciech, Trelińska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224825/
https://www.ncbi.nlm.nih.gov/pubmed/35743464
http://dx.doi.org/10.3390/jcm11123395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224825/
https://www.ncbi.nlm.nih.gov/pubmed/35743464
http://dx.doi.org/10.3390/jcm11123395

Ejemplares similares